Press release
Rare Kidney Diseases Market Exclusive Trends Analysis with Forecast to 2034
Get A Free Report Brochure:
https://www.insightaceanalytic.com/request-sample/1414
Rare kidney diseases encompass a group of uncommon renal disorders that result in impaired kidney function, leading to toxin accumulation in the body and subsequent health complications. Many of these conditions have a genetic or hereditary origin and occur infrequently within the general population.
Key disorders in this category include Lupus Nephritis, Membranous Nephropathy, Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy, and C3 Glomerulopathy. Among these, IgA Nephropathy is distinguished by the deposition of IgA antibodies in kidney tissues, which triggers inflammation and may progress to kidney failure.
List of Prominent Players in the Rare Kidney Diseases Market:
• GlaxoSmithKline,
• Recordati Rare Diseases,
• Amicus Therapeutics,
• Calliditas Therapeutics,
• Alexion Pharmaceuticals (A subsidiary of AstraZeneca),
• Travere Therapeutics,
• Aurinia Pharmaceutical,
• Advicenne,
• Protalix Biotherapeutics,
• AstraZeneca,
• Chinook Therapeutics,
• Reata Pharmaceuticals,
• Roche,
• Novartis Pharmaceuticals,
• Merk & co.,
• Apellis Pharmaceuticals,
• Omeros Corporation,
• Lonza
Market Dynamics:
Drivers-
The rare kidney disease market is experiencing substantial growth, driven by several key factors. One of the primary contributors is the expanding pipeline of innovative treatments, with over 21,630 participants currently enrolled in clinical trials assessing therapies at various developmental stages. The rising global prevalence of rare renal disorders has heightened the demand for advanced and effective treatment solutions, leading to increased investment in this sector.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1414
Challenges:
Despite advancements in research and drug development, several challenges continue to impede the growth of the rare kidney disease market. Research funding and healthcare systems tend to prioritize more prevalent diseases, often leaving rare kidney disorders underfunded and overlooked. Additionally, limited data availability on these conditions creates gaps in research, healthcare policies, and clinical care.
Regional Trends:
North America is expected to lead the rare kidney disease market, holding a significant revenue share and registering a high compound annual growth rate (CAGR) in the coming years. Several factors contribute to this regional dominance, including the increasing incidence of rare renal conditions such as Fabry disease, lupus nephritis, nephropathic cystinosis, and atypical hemolytic uremic syndrome. Furthermore, greater government and nonprofit funding for research, higher healthcare expenditures, early adoption of advanced technologies, and the widespread acceptance of innovative diagnostic and therapeutic solutions are expected to drive market growth in the region.
Recent Developments:
• In August 2023, Novartis completed the purchase of US clinical-stage biopharmaceutical company Chinook Therapeutics. Chinook Therapeutics develops kidney-specific drugs. An initial $3.2 billion payment was made, with a possible $3.5 billion purchase value.
• In March 2024, Travere Therapeutics, Inc. filed a sNDA to the FDA to convert FILSPARI® (sparsentan)'s expedited approval in IgAN to full approval. FILSPARI, the first and only non-immunosuppressive medication to treat kidney glomerular degeneration and proteinuria in primary IgAN patients at risk of fast disease progression, received expedited FDA clearance in February 2023.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1414
Segmentation of Rare Kidney Diseases Market-
By Target Indication-
• IgA Nephropathy
• Lupus Nephritis
• Focal Segmental Glomerular Sclerosis
• Membranous Nephropathy
• C3 Glomerulopathy
• Cystinosis
• Dense Deposit Disease
• Distal Renal Tubular Acidosis
• Fabry Disease
• Refractory Gout
• Atypical Hemolytic Uremic Syndrome
• Others
By Type of Molecule-
• Small Molecules
• Biologics
o Monoclonal Antibody
o Hormone
o Recombinant Protein
o Others
By Route of Administration-
• Oral
• Intravenous
• Subcutaneous
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-rare-kidney-diseases-market-/1414
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rare Kidney Diseases Market Exclusive Trends Analysis with Forecast to 2034 here
News-ID: 4152133 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
3D Printing Construction Market Top Companies Study - COBOD International A/S; Y …
"3D Printing Construction Market" in terms of revenue was estimated to be worth USD 11.9 Billion in 2024 and is poised to reach USD 1,231.6 Billion by the year 2034, growing at a CAGR of 59.2% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1604
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 3D…
Digital Twin Market Forecast Indicates Robust Demand for Predictive Maintenance …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Twin Market Size, Share & Trends Analysis Report By Type (System Digital Twin, Product Digital Twin, Process Digital Twin), Application Area (Business Optimization, Predictive Maintenance, Production Design and Development, Others), Industry (Aerospace & Defense, Automotive & Transportation, Home & Commercial, Healthcare, Energy & Utilities, Oil & Gas, Agriculture, Telecommunication, Others)- Market Outlook And Industry…
E-Commerce Logistics Market Insights Show Increasing Adoption of Automated Wareh …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 Billion by the year 2034, exhibiting a CAGR of 26.4% during the forecast period.
Get Free Access…
E-Bike Battery Pack Market Expansion Driven by Rising Popularity of Pedelecs and …
The global e-bike battery pack market is estimated to reach over USD 45.1 Billion by the year 2034, exhibiting a CAGR of 15.2% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1594
An e-bike battery pack functions as a rechargeable power source designed to drive the electric motor of an electric bicycle, enabling propulsion with reduced or no pedaling effort. These battery systems are available…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
